Skip to content
MedsAcross

Brand family

Tyzavan

Vancomycin · Hikma Pharmaceuticals
United States
Presentations
7
Markets
1

Tyzavan is a brand of Vancomycin marketed by Hikma Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Vancomycin
Brand owner
Hikma Pharmaceuticals
Registered in
United States
Strengths and forms
1 g/200 mL injection, 1.25 g/250 mL injection, 1.5 g/300 mL injection, 1.75 g/350 mL injection, 2 g/400 mL injection, 500 mg/100 mL injection, 750 mg/150 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Tyzavan 1 g/200 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 1.25 g/250 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 1.5 g/300 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 1.75 g/350 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 2 g/400 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 500 mg/100 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request
Tyzavan 750 mg/150 mL injectionIntravenousHikma PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Vancomycin.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Tyzavan

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.